Recently, it was demonstrated that tetracaine derivative EL20 specifically inhibits mutant RyR2, normalizes Ca2+ handling and suppresses arrhythmias in a CPVT mouse model. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.